You have 0 Articles Left This Month. Register Today for Unlimited Access.
Calling the proposal “incomplete and financially inadequate,” Monsanto Company’s board of directors declined German pharmaceutical company Bayer AG’s offer to purchase the company for $62 billion.
But the global agricultural company didn’t close the door entirely, adding it is open to continuing discussions to see if a transactions in the best interest of its shareholders can be reached.
You have 0 complimentary articles left.
Register for free today to continue reading!
Already have an account? Sign in here.